Sesame Care Tirzepatide Review: Cost, Brand Access & Honest Verdict (2026)

Sesame is one of the most established national telehealth marketplaces (operating since 2018), LegitScript-certified and BBB-listed with a large volume of public reviews. For tirzepatide it stands out for the widest real brand-name access in our ranking — brand Zepbound and Mounjaro plus Wegovy, Ozempic, and oral Rybelsus. The catch is that it is a generalist marketplace with a two-part cost, not a flat-price weight-loss program. This review covers what Sesame is, what it dispenses, the brand-versus-compounded distinction, its real pricing, and the catches. We disclose an affiliate relationship with Sesame; it never changes our scoring, and every fact here comes from Sesame's own platform.

What Sesame Care is

Sesame (sesamecare.com) is a national telehealth marketplace rather than a single dedicated weight program. Instead of one in-house clinic, it connects patients to independent clinicians and pharmacies and lets you compare options. It has been operating since 2018, is LegitScript-certified and BBB-listed, and carries a large volume of public reviews — an unusually long track record for this category. For weight care it offers the widest brand-name access we track: the FDA-approved brand tirzepatide products Zepbound and Mounjaro, plus Wegovy (pen and pill), Ozempic, and oral Rybelsus. Because it is a marketplace, brand medication is billed separately from a Sesame platform subscription, so the true cost is two-part.

The brand-vs-compounded question

Two very different products share the name tirzepatide:

• •Brand tirzepatide is Eli Lilly's FDA-approved Zepbound (weight management, obstructive sleep apnea) and Mounjaro (type 2 diabetes) — the exact molecule and dose studied in the pivotal trials.
• •Compounded tirzepatide is pharmacy-made, not FDA-approved, and was not the product tested in those trials.

Here Sesame is on the brand side of that line: for tirzepatide it routes the FDA-approved brand-name Zepbound and Mounjaro, not a compounded copy. That is a genuine advantage over the many compounded-only telehealth startups, and it matters more in 2026 — the FDA declared the tirzepatide shortage resolved in October 2024, and the enforcement discretion that permitted routine large-scale compounding ended in early 2025 (around February 18, 2025 for 503A pharmacies, March 19, 2025 for 503B outsourcing facilities). The full timeline is in our guide to whether compounded tirzepatide is still legal in 2026. The trade-off for that brand access is cost: brand tirzepatide is priced far above compounded options.

What Sesame Care costs in 2026

Sesame's cost is two-part: the brand medication is priced by the individual marketplace listing (which varies), billed separately from a Sesame platform subscription. There is no single flat monthly figure the way a dedicated compounded program quotes one. Because listings and clinician prices vary, confirm the total — subscription plus medication — before you commit.

For context on the brand drug itself, LillyDirect sells brand Zepbound self-pay vials at roughly $299–$449/month depending on dose (prices effective February 23, 2026; 28-day supply). Brand tirzepatide through any route, Sesame included, sits well above the ~$99–$299/month compounded market. For the full cash-price picture, see our Zepbound cost and savings guide.

How the care model holds up

Sesame's strengths are real: it is one of the most established telehealth marketplaces, LegitScript-certified and BBB-listed with a large review volume, it dispenses FDA-approved brand products rather than a compounded copy, and it offers the widest brand-name access we track. The trade-offs are equally real: the two-part cost (subscription plus separately billed medication) means no flat all-in price; brand pricing varies by listing and is typically far higher than compounded options; it is a generalist marketplace, not a weight-loss-specialized program with built-in coaching; and because care runs through independent clinicians and pharmacies, continuity and exactly what you are dispensed can vary. As with any GLP-1 service, confirm continuity of care and read the cancellation terms; tirzepatide carries labeled warnings for acute pancreatitis, gallbladder disease, and a boxed thyroid C-cell tumor warning — see our guides on Zepbound side effects, the gallbladder risk, and the thyroid cancer warning.

Does the drug work? (Separate from the provider)

Separate the provider from the medication. Because Sesame routes the brand molecule, its tirzepatide is the trial-grade product: in the 72-week SURMOUNT-1 trial, adults without diabetes lost on average roughly 15% to 21% of body weight across the 5–15 mg doses, versus about 3% on placebo¹; against semaglutide in SURMOUNT-5, tirzepatide produced significantly greater weight loss — about 20% versus 14%². Those results were established with exactly the brand molecule Sesame dispenses. The full picture is in our tirzepatide evidence guide.

The honest verdict

Sesame is a strong pick if your priority is brand, FDA-approved tirzepatide from an established, well-reviewed marketplace with the widest brand access — and you accept a two-part cost and the variability of a generalist marketplace. The reservations are the lack of a flat all-in price, brand pricing that runs well above compounded options, and the fact that it is not a weight-loss-specialized program with built-in coaching. If you want a low flat price with included nurse/dietitian support, weigh CoreAge Rx; if you specifically want the cheapest brand-tirzepatide route, price Sesame's listings against LillyDirect. See our best tirzepatide providers ranking and best place to get Zepbound online roundup.